StockTipsArenaBeta

BUY Aurobindo Pharma — Chandan Taparia, Motilal Oswal

BUYAurobindo Pharma
Aurobindo Pharma share price target & all analyst calls

byChandan Taparia, Motilal OswalHorizon: NA (inferred Swing (≤2wk))6 Apr 2026via ET Now

Entry₹1,340.4Inferred
Target₹1,400
Total upside +4.45% (call closed)
Stop lossNot given
At expiry₹1,36520 Apr 2026, 3:30 pm
Expired+1.84%
Follow Chandan Taparia for new calls(30% target hit, 259 closed calls)Get alertsWatch AUROPHARMA for new buy/sell callsGet alertsSee 1 active Swing call on AUROPHARMASee 149 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 25 Oct, 10:50 pm IST
2 supporting1 neutral0 opposing
Supports the BUY call (2)

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·7 Apr · 2w ago

2 advisors have active short-term BUY calls on this stock

Advisor consensus · adjacent horizon·6 Apr · 2w ago

Neutral / worth noting (1)

Upcoming Stock Split, Dividend, Bonus Issue THIS Week: Aurobindo Pharma, Muthoot Finance, More | Full List

NewsGoogle News·12 Apr · 1w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Aurobindo Pharma

All analyst calls on Aurobindo Pharma

More from Chandan Taparia, Motilal Oswal

Every call and its outcome